# Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea

> **NCT01060748** · PHASE2 · COMPLETED · sponsor: **TD Vaccines A/S** · enrollment: 70 (actual)

## Conditions studied

- Diarrhea

## Interventions

- **BIOLOGICAL:** ACE527
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT01060748
- **Lead sponsor:** TD Vaccines A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-10
- **Final completion:** 2010-10
- **Target enrollment:** 70 (ACTUAL)
- **Last updated:** 2011-03-07

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01060748

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01060748, "Safety and Efficacy Study of a Vaccine Against Enterotoxigenic Escherichia Coli (ETEC) to Prevent Moderate to Severe Diarrhea". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01060748. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*